ScinoPharm Taiwan Ltd (1789) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.019x

Based on the latest financial reports, ScinoPharm Taiwan Ltd (1789) has a cash flow conversion efficiency ratio of 0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$199.47 Million ≈ $6.28 Million USD) by net assets (NT$10.31 Billion ≈ $324.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 1789 company net worth for the company's overall valuation and market capitalisation.

ScinoPharm Taiwan Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ScinoPharm Taiwan Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ScinoPharm Taiwan Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ScinoPharm Taiwan Ltd ranked by their cash flow conversion efficiency. Explore how high is ScinoPharm Taiwan Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Arko Corp NASDAQ:ARKO	0.033x
Apex Healthcare Bhd KLSE:7090	0.038x
KT Submarine Co. Ltd KQ:060370	0.022x
Tianjin Jieqiang Power Equipment Co SHE:300875	-0.007x
Diamond Hill Investment Group Inc NASDAQ:DHIL	0.095x
Hubei Xiangyuan New Material Technology Inc. SHE:300980	0.004x
B+S GROUP SA INH EO-06 F:70B	N/A
ICRA Limited NSE:ICRA	0.071x

Annual Cash Flow Conversion Efficiency for ScinoPharm Taiwan Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of ScinoPharm Taiwan Ltd from 2007 to 2025. View 1789 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$10.52 Billion ≈ $331.59 Million	NT$597.11 Million ≈ $18.81 Million	0.057x	-20.47%
2024-12-31	NT$10.53 Billion ≈ $331.62 Million	NT$750.91 Million ≈ $23.66 Million	0.071x	+219.91%
2023-12-31	NT$10.36 Billion ≈ $326.54 Million	NT$231.13 Million ≈ $7.28 Million	0.022x	-69.88%
2022-12-31	NT$10.45 Billion ≈ $329.23 Million	NT$773.79 Million ≈ $24.38 Million	0.074x	+52.66%
2021-12-31	NT$10.51 Billion ≈ $331.16 Million	NT$509.82 Million ≈ $16.06 Million	0.049x	-46.03%
2020-12-31	NT$10.53 Billion ≈ $331.73 Million	NT$946.31 Million ≈ $29.81 Million	0.090x	+16.88%
2019-12-31	NT$10.26 Billion ≈ $323.24 Million	NT$788.95 Million ≈ $24.86 Million	0.077x	-34.20%
2018-12-31	NT$10.54 Billion ≈ $332.04 Million	NT$1.23 Billion ≈ $38.80 Million	0.117x	+25.28%
2017-12-31	NT$10.42 Billion ≈ $328.20 Million	NT$971.71 Million ≈ $30.61 Million	0.093x	-42.70%
2016-12-31	NT$10.23 Billion ≈ $322.23 Million	NT$1.67 Billion ≈ $52.46 Million	0.163x	+53.63%
2015-12-31	NT$9.86 Billion ≈ $310.55 Million	NT$1.04 Billion ≈ $32.91 Million	0.106x	+11.90%
2014-12-31	NT$9.38 Billion ≈ $295.53 Million	NT$888.29 Million ≈ $27.99 Million	0.095x	-2.80%
2013-12-31	NT$9.64 Billion ≈ $303.82 Million	NT$939.47 Million ≈ $29.60 Million	0.097x	-9.97%
2012-12-31	NT$9.07 Billion ≈ $285.78 Million	NT$981.55 Million ≈ $30.92 Million	0.108x	-28.44%
2011-12-31	NT$8.56 Billion ≈ $269.67 Million	NT$1.29 Billion ≈ $40.78 Million	0.151x	-35.46%
2010-12-31	NT$6.68 Billion ≈ $210.37 Million	NT$1.56 Billion ≈ $49.29 Million	0.234x	-19.27%
2009-12-31	NT$4.47 Billion ≈ $140.89 Million	NT$1.30 Billion ≈ $40.89 Million	0.290x	-29.06%
2008-12-31	NT$3.44 Billion ≈ $108.39 Million	NT$1.41 Billion ≈ $44.34 Million	0.409x	+105.43%
2007-12-31	NT$2.53 Billion ≈ $79.82 Million	NT$504.50 Million ≈ $15.89 Million	0.199x	--

About ScinoPharm Taiwan Ltd

TW:1789 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$473.34 Million

NT$15.02 Billion TWD

Market Cap Rank

#12647 Global

#472 in Taiwan

Share Price

NT$19.00

Change (1 day)

-3.06%

52-Week Range

NT$16.75 - NT$28.25

All Time High

NT$55.57